HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HRA Pharma Sees Good Prospects For Austria

Executive Summary

HRA tells HBW Insight that it is seeing “a lot of growth opportunities” in the Austrian market as it takes back direct distribution of its leading consumer healthcare brands.

You may also be interested in...



South Africa Next As HRA Pharma Marches On With Global Expansion

HRA Pharma brings Compeed to South Africa, moving the company one step closer to achieving its goal of becoming a top-10 global consumer healthcare player. 

Neuraxpharm Underlines OTC Ambitions With Easypharm Acquisition

Austria's Easypharm has been snapped up by Neuraxpharm, which is looking to take a larger slice of Europe's consumer healthcare market.

HRA Pharma Taking On China With JV Partner

HRA is putting feet on the ground in China as it looks to establish itself in the world second-largest consumer health market. 

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS149665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel